Bosentan treatment results in sustained improvement of endothelial dysfunction in patients with Systemic Sclerosis: A controlled, two-month, prospective study

被引：0
|
作者：
Papamichael, C
Fragiadaki, KG
Stamatelopoulos, K
Katsichti, V
Mavrikakis, M
Sfikakis, PP
机构：
[1] Univ Athens, Sch Med, Dept Therapeut, GR-11527 Athens, Greece
[2] Univ Athens, Sch Med, Dept Prop Internal Med 1, GR-11527 Athens, Greece
来源：
ARTHRITIS AND RHEUMATISM | 2004年 / 50卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S631 / S632
页数：2
相关论文
共 50 条
  • [1] Bosentan and its effects on endothelial dysfunction in patients with severe raynaud's phenomenon in systemic sclerosis
    Hettema, M. E.
    Zhang, D.
    Kallenberg, C. G. M.
    Bootsma, H.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : 210 - 210
  • [2] Improvement of vascular endothelial function using the oral endothelin receptor antagonist Bosentan in patients with systemic sclerosis
    Sfikakis, P. P.
    Papamichael, C.
    Starnatelopoulos, K. S.
    Tousoulis, D.
    Fragiadaki, K. G.
    Katsichti, P.
    Stefanadis, C.
    Mavrikakis, M.
    [J]. ARTHRITIS AND RHEUMATISM, 2007, 56 (06): : 1985 - 1993
  • [3] Clinical and hepatic evaluation in adult dengue patients: a prospective two-month cohort study
    Tristao-Sa, Ricardo
    Kubelka, Claire Fernandes
    Zandonade, Eliana
    Oliveira Zagne, Sonia Maria
    Maciel Rocha, Natally de Souza
    Zagne, Luiza Oliveira
    Araujo, Nathalia Felix
    Amin, Beatriz
    Fazoli, Flavia
    de Souza, Luiz Jose
    Cruz, Oswaldo Goncalves
    da Cunha, Rivaldo Venancio
    do Nascimento, Delso
    Froes, Iris Bucher
    Ribeiro Nogueira, Rita Maria
    [J]. REVISTA DA SOCIEDADE BRASILEIRA DE MEDICINA TROPICAL, 2012, 45 (06) : 675 - 681
  • [4] Improvement of markers endothelial damage in patients with pulmonary arterial hypertension (PAH) related to systemic sclerosis (SSC) after bosentan treatment.
    Del Papa, N
    Cortiana, M
    Comina, D
    Maglione, W
    Silvestris, I
    Manara, M
    Maresta, A
    Cortelezzi, A
    [J]. ARTHRITIS AND RHEUMATISM, 2005, 52 (09): : S164 - S164
  • [5] Bosentan for Digital Ulcers in Patients with Systemic Sclerosis: A Prospective 3-year Followup Study
    Tsifetaki, Niki
    Botzoris, Vassilios
    Alamanos, Yannis
    Argyriou, Evaggelia
    Zioga, Aikaterini
    Drosos, Alexandros A.
    [J]. JOURNAL OF RHEUMATOLOGY, 2009, 36 (07) : 1550 - 1552
  • [6] Oropharyngeal Dysfunction in Patients with Systemic Sclerosis - Results of a Monocentric Clinical Study
    Klemm, Philipp
    Wirths, Mirjam
    Hudowenz, Ole
    Hoffmann, Ulrike
    Mueller-Ladner, Ulf
    Lange, Uwe
    [J]. ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [7] TREATMENT OF DIGITAL ULCERS IN PATIENTS WITH SYSTEMIC SCLEROSIS: PROSPECTIVE COHORT STUDY
    Chang, S. H.
    Jun, J. B.
    Lee, Y. J.
    Kang, T. Y.
    Park, Y.
    Lee, S. G.
    Lee, S. S.
    Lee, E. B.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 695 - 695
  • [8] THE EFFECTS OF BOSENTAN FOR TREATMENT OF DIGITAL ULCER IN KOREAN PATIENTS WITH SYSTEMIC SCLEROSIS: PROSPECTIVE, MULTICENTER, OPEN-LABEL TRIAL
    Lee, Kyung Ann
    Kim, Hyun-Sook
    Kim, Bo Young
    Kim, Yun Sung
    Choi, Sung Jae
    Choi, Jung Ran
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 1795 - 1796
  • [9] Effects of prostaglandin E1α cyclodestrin treatment on endothelial dysfunction in patients with systemic sclerosis
    Giannattasio, Cristina
    Pozzi, MariaRosa
    Gradinali, Marco
    Montemerlo, Elisabetta
    Citterio, Francesca
    Maestroni, Silvia
    Fantini, Elena
    Failla, Monica
    Robuschi, Maria
    Bianco, Salvatore
    Mancia, Giuseppe
    [J]. JOURNAL OF HYPERTENSION, 2007, 25 (04) : 793 - 797
  • [10] Bosentan for digital ulcers in patients with systemic sclerosis. A prospective 3-year follow-up study
    Tsifetaki, Niki
    Botzoris, Vasilios G.
    Argyriou, Evagelia
    Drosos, Alexandros A.
    [J]. ARTHRITIS AND RHEUMATISM, 2008, 58 (09): : S825 - S825
12345